|
GPN1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.219800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.230600E-01 |
| Normal-vs-Stage2 |
1.676360E-01 |
| Normal-vs-Stage3 |
2.227000E-01 |
| Normal-vs-Stage4 |
5.468400E-01 |
| Stage1-vs-Stage2 |
6.424300E-02 |
| Stage1-vs-Stage3 |
4.557000E-01 |
| Stage1-vs-Stage4 |
8.695400E-01 |
| Stage2-vs-Stage3 |
2.528400E-02 |
| Stage2-vs-Stage4 |
9.551700E-02 |
| Stage3-vs-Stage4 |
7.030000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.999360E-01 |
| Normal-vs-AfricanAmerican |
9.649500E-02 |
| Normal-vs-Asian |
9.826200E-01 |
| Caucasian-vs-AfricanAmerican |
5.014800E-01 |
| Caucasian-vs-Asian |
3.978200E-01 |
| AfricanAmerican-vs-Asian |
2.214600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.748000E-01 |
| Normal-vs-Female |
3.598200E-01 |
| Male-vs-Female |
2.924800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.854590E-01 |
| Normal-vs-Age(41-60Yrs) |
8.485800E-01 |
| Normal-vs-Age(61-80Yrs) |
7.251800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.079000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.047220E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.052400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.078200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.866200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.381000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.608800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.638500E-02 |
| Classical-VS-Follicular |
1.95749999998274E-06 |
| Classical-VS-Other |
1.079610E-01 |
| Classical-VS-Normal |
5.940300E-02 |
| Tall-VS-Follicular |
1.54387999999894E-05 |
| Tall-VS-Other |
1.697690E-02 |
| Tall-VS-Normal |
2.742300E-03 |
| Follicular-VS-Other |
8.604000E-01 |
| Follicular-VS-Normal |
4.499100E-03 |
| Other-VS-Normal |
3.824400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.592800E-01 |
| Normal-vs-N1 |
4.638800E-01 |
| N0-vs-N1 |
8.747000E-01 |
|
|
